EUVIMEDEUVIMED entdecken
Crossref

Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer’s Disease

Takumi Nakamura, Takeshi Kawarabayashi, Tetsuya Ueda, Sachiko Shimomura, Masaki Hoshino, Ken Itoh, Kazushige Ihara, Shigeyuki Nakaji, Masamitsu Takatama, Yoshio Ikeda, Mikio Shoji

Journal of Alzheimer's Disease · 2023

DOI: 10.3233/jad-220996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von Takumi Nakamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloidosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

APOE4 is the strongest risk factor for Alzheimer’s disease (AD). However, limited information is currently available on APOE4 and the pathological role of plasma apolipoprotein E (ApoE) 4 remains unclear.

Objective

The aims of the present study were to measure plasma levels of total ApoE (tE), ApoE2, ApoE3, and ApoE4 using mass spectrometry and elucidate the relationships between plasma ApoE and blood test items.

Methods

We herein examined plasma levels of tE, ApoE2, ApoE3, and ApoE4 in 498 subjects using liquid chromatograph-mass spectrometry (LC-MS/MS).

Results

Among 498 subjects, mean age was 60 years and 309 were female. tE levels were distributed as ApoE2/E3 = ApoE2/E4 >ApoE3/E3 = ApoE3/E4 >ApoE4/E4. In the heterozygous group, ApoE isoform levels were distributed as ApoE2 >ApoE3 >ApoE4. ApoE levels were not associated with aging, the plasma amyloid-β (Aβ) 40/42 ratio, or the clinical diagnosis of AD. Total cholesterol levels correlated with the level of each ApoE isoform. ApoE2 levels were associated with renal function, ApoE3 levels with low-density lipoprotein cholesterol and liver function, and ApoE4 levels with triglycerides, high-density lipoprotein cholesterol, body weight, erythropoiesis, and insulin metabolism.

Conclusion

The present results suggest the potential of LC-MS/MS for the phenotyping and quantitation of plasma ApoE. Plasma ApoE levels are regulated in the order of ApoE2 >ApoE3 >ApoE4 and are associated with lipids and multiple metabolic pathways, but not directly with aging or AD biomarkers. The present results provide insights into the multiple pathways by which peripheral ApoE4 influences the progression of AD and atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloidosisFemaleHumansMaleApolipoprotein E2Apolipoprotein E4Apolipoprotein E3Chromatography, LiquidTandem Mass SpectrometryApolipoproteins ECholesterolBiomarkersProtein Isoforms

Stichwörter der Autor:innen

Alzheimer’s diseaseApoEHDLLDLamyloid-βbiomarkerscholesterolisoform

Substanzen

Apolipoprotein E2Apolipoprotein E4Apolipoprotein E3Apolipoproteins ECholesterolBiomarkersProtein Isoforms

Autor:innen und Institutionen

  • Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of Social Medicine, Hirosaki University School of Medicine, Hirosaki, Japan.
  • Department of Neurology, Geriatrics Research Institute and Hospital, Maebashi, Japan.
  • Bioanalysis Department, LSI Medience Corporation, Itabashi-ku, Tokyo, Japan.
  • Department of Stress Response Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Zitieren

APA

Nakamura, T., Kawarabayashi, T., Ueda, T., Shimomura, S., Hoshino, M., Itoh, K., Ihara, K., Nakaji, S., Takatama, M., Ikeda, Y., & Shoji, M. (2023). Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer’s Disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-220996

Vancouver

Nakamura T, Kawarabayashi T, Ueda T, Shimomura S, Hoshino M, Itoh K, et al. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer’s Disease. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-220996

BibTeX
@article{Nakamura2023,
  author = {Nakamura, Takumi and Kawarabayashi, Takeshi and Ueda, Tetsuya and Shimomura, Sachiko and Hoshino, Masaki and Itoh, Ken and Ihara, Kazushige and Nakaji, Shigeyuki and Takatama, Masamitsu and Ikeda, Yoshio and Shoji, Mikio},
  title = {Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer’s Disease},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  doi = {10.3233/jad-220996}
}
Kostenlos starten →